Search Results - "Nicolò, Massimo"
-
1
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases
Published in Expert opinion on investigational drugs (04-03-2021)“…Intravitreal antivascular endothelial growth factor (VEGF) drugs represent the first-line treatment option for wet age-related macular degeneration (w-AMD) and…”
Get more information
Journal Article -
2
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degeneration
Published in Expert opinion on investigational drugs (02-07-2020)“…Several approaches have been investigated for the management of wet age-related macular degeneration (w-AMD); however, the first-line treatment option for…”
Get more information
Journal Article -
3
Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography
Published in Investigative ophthalmology & visual science (01-04-2017)“…To report the choroidal vascular flow area in eyes with central serous chorioretinopathy (CSC) compared with healthy subjects and unaffected fellow eyes using…”
Get full text
Journal Article -
4
Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT
Published in Graefe's archive for clinical and experimental ophthalmology (01-05-2020)“…Purpose The aim of this study was to evaluate changes in choroidal thickness and in choroidal vascular blood flow in patients with thyroid-associated…”
Get full text
Journal Article -
5
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases
Published in Expert opinion on therapeutic targets (01-02-2022)“…Several approaches have been investigated for treating wet age-related macular degeneration (w-AMD), diabetic macular edema (DME) and retinal vein occlusions…”
Get more information
Journal Article -
6
Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy
Published in American journal of ophthalmology (01-12-2022)“…To evaluate whether frequent vigorous physical activity (PA) is significantly associated with active central serous chorioretinopathy (CSCR) and may represent…”
Get full text
Journal Article -
7
Reply to Comment on: Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy
Published in American journal of ophthalmology (01-05-2023)Get full text
Journal Article -
8
Reply to Comment on “Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy”
Published in American journal of ophthalmology (01-05-2023)Get full text
Journal Article -
9
Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients
Published in Schizophrenia research (01-06-2020)Get full text
Journal Article -
10
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Published in Pharmaceutics (05-05-2023)“…Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative…”
Get full text
Journal Article -
11
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Published in International ophthalmology (01-02-2021)“…Purpose The current coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization a global pandemic. Chloroquine (CQ) and…”
Get full text
Journal Article -
12
Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
Published in Investigative ophthalmology & visual science (01-08-2018)“…To investigate by optical coherence tomography angiography (OCT-A) the choroidal vascular response to experimentally increased blood pressure in patients with…”
Get full text
Journal Article -
13
Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration
Published in Expert opinion on biological therapy (03-08-2019)“…: Although several approaches have been studied for treating wet age-related macular degeneration (w-AMD), currently, the most effective strategy in the…”
Get more information
Journal Article -
14
Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Published in Pharmaceuticals (Basel, Switzerland) (23-09-2020)“…Central serous chorioretinopathy (CSC) is a common cause of visual impairment in patients generally aged 20 to 60 and it is characterized by acute or chronic…”
Get full text
Journal Article -
15
PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration
Published in Graefe's archive for clinical and experimental ophthalmology (01-10-2022)“…Purpose PERSEUS-IT (NCT02289924) was a prospective, observational, 2-year study evaluating the effectiveness and treatment patterns of intravitreal aflibercept…”
Get full text
Journal Article -
16
Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis
Published in Archives of gynecology and obstetrics (01-08-2022)“…Correspondence to the original research entitled “Effects of ranibizumab and zoledronic acid on endometriosis in a rat model” published by Ozdemir et al…”
Get full text
Journal Article -
17
Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study
Published in American journal of ophthalmology (01-03-2020)“…To compare optical coherence tomography-angiography (OCT-A) performed during physical exercise (stress OCT-A) to the basal examination (rest OCT-A) in the…”
Get full text
Journal Article -
18
Bilateral choroidal detachment and myopic shift after acetazolamide intake for laser capsulotomy
Published in European journal of ophthalmology (01-01-2022)“…Introduction: To report a case of bilateral choroidal effusion after laser capsulotomy. Case description: A healthy 85 years old white woman was referred to…”
Get full text
Journal Article -
19
Prechoroidal Cleft Regression After Switch to Intravitreal Brolucizumab
Published in European journal of ophthalmology (01-01-2024)“…Introduction Prechoroidal cleft has been described as a negative prognostic biomarker in patients affected with neovascular age related macular degeneration…”
Get full text
Journal Article -
20
Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy
Published in European journal of ophthalmology (24-04-2024)“…Purpose: To assess the role of artificial intelligence (AI) based automated software for detection of Diabetic Retinopathy (DR) compared with the evaluation of…”
Get full text
Journal Article